[Treatment of symptomatic hemolytic anemias].
D000743:Anemia, Hemolytic; D006689:Hodgkin Disease / Q000150:complications*; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008466:Mechlorethamine; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D012509:Sarcoma
D009588:Nitrogen Mustard Compounds; D008466:Mechlorethamine
ANEMIA, HEMOLYTIC; HODGKIN'S DISEASE/complications; NITROGEN MUSTARDS/therapeutic use; SARCOMA, RETICULUM CELL
Zur Therapie symptomastischer hämolytischer Anämien.